✦ LIBER ✦

311 POSTER In vivo antitumor efficacy of TAK-285, a novel ErbB1/ErbB2 dual kinase inhibitor

✍ Scribed by A. Iwahara; T. Tamura; S. Takagi; H. Kamiguchi; T. Yusa; Y. Ohta

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

314 POSTER Combined antitumor efficacies

✍ T. Tamura; S. Takagi; K. Horikoshi; T. Yusa; M. Koyama; H. Tojo; Y. Ohta 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

313 POSTER Novel inhibitory mechanisms o

✍ S.A. Shell; K.J. Pry; P. Trusk; R.L. Wappel; Y. Ohta; W. Klohs; S.S. Bacus 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

3509 POSTER Growth inhibitory effects an

✍ J.W. Kim; S.A. Im; H.P. Kim; D.Y. Oh; T.Y. Kim; Y.J. Bang 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Lapatinib, a Dual ErbB-1/ErbB-2 Kinase I

✍ Susan R. Peck; Joyce A. O'Shaughnessy 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 95 KB

Inhibition of ErbB1 and ErbB2 by Lapatin

✍ Kavita Maung; Joyce A. O'Shaughnessy 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 90 KB

Antitumor activity of a dual epidermal g

✍ Tsuyoshi Suzuki; Akihiro Fujii; Junichi Ohya; Hideo Nakamura; Fumiko Fujita; Mas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 651 KB